Scope of the Study
Digital Telepathology is the practice of remote pathology using telecommunication links to enable the electronic transmission of digital pathology images and it can be used for remotely rendering primary diagnoses, quality assurance, second opinion consultations, and research and education purposes. Digital Telepathology is used to aid a growing number of laboratories around the world to deliver pathology services by allowing them to easily connect with professionals. Telepathology is also used to enhance the efficiency of pathology services between hospitals less than a mile apart, and this has led to significant growth of the digital telepathology market over the forecast period.
The market study is being classified by Type (Dynamic, Static and Hybrid), by Application (Diagnosis, Education, Research and Others) and major geographies with country level break-up.
GE Healthcare (United States), Leica Biosystems Nussloch GmbH (Germany), Ventana Medical Systems, Inc. (United States), Olympus Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Mikroscan Technologies, Inc. (United States), Diagnostic Instruments Inc (United States), eVisit Telemedicine Solution (United States), Teleconsult Europe (Netherlands) and Unilabs (Switzerland) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are SRL Diagnostics (India) and Apollo Tele Health Services (India).
The Players having a strong hold in the market are GE Healthcare, Leica Biosystems Nussloch GmbH, Ventana Medical Systems, Inc., and Olympus Corporation. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Digital Telepathology market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Digital Telepathology market by Type, Application and Region.
On the basis of geography, the market of Digital Telepathology has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Clinical Urgency to Accept Telepathology to Improve Present Patient Diagnostic Imaging Events
- High costs associated with Conventional Diagnostics is Driving the Growth of Digital Telepathology Market
- Rising Digitalization and Information Technology across the Globe
- High Cost of Telepathology Devices
- Growing Prevalence of Chronic Diseases and Technological Advancements in the Healthcare Industry
- Scarcity of Skilled Professionals is Hindering the Market Growth
- Digital Telepathology has limited mostly to Large Academic Institutions
July 31st, 2018 – Leica Biosystems has announced that its live view telepathology system, the Aperio LV1 IVD, can now be used for on-screen diagnosis in Europe, Canada, New Zealand, and Australia. This compact Digital Pathology system, with a capacity of 4 slides, navigates like a conventional microscope, but with a host of digital benefits.
Key Target AudiencePharmaceutical & Biotechnology Companies, Research Institutes, Software and hardware companies, Government Organizations, Business Consulting Firms and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase